We are live on ! Find out more
RCAMU

Rothschild & Co Asset Management US Portfolio holdings

AUM $6.58B
1-Year Est. Return 4.5%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
-4.5%
3 Year Est. Return
+63.72%
5 Year Est. Return
+103.96%
10 Year Est. Return
AUM
$9.24B
AUM Growth
-$130M
Cap. Flow
-$190M
Cap. Flow %
-2.05%
Top 10 Hldgs %
12.25%
Holding
362
New
11
Increased
110
Reduced
214
Closed
15

Top Buys

Rank Stock Value
1
KMB icon
Kimberly-Clark
KMB
+$43.2M
2
TXT icon
Textron
TXT
+$33.4M
3
CF icon
CF Industries
CF
+$30.1M
4
MMSI icon
Merit Medical Systems
MMSI
+$30M
5
GBCI icon
Glacier Bancorp
GBCI
+$28.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$61M
2
ESNT icon
Essent Group
ESNT
+$38.1M
3
AGN
Allergan plc
AGN
+$35.4M
4
EME icon
Emcor
EME
+$28.2M
5
CVX icon
Chevron
CVX
+$27.8M

Sector Composition

Rank Sector Weight
1 Financials 17.58%
2 Industrials 14.58%
3 Healthcare 12.79%
4 Technology 11.13%
5 Consumer Discretionary 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAH icon
351
Booz Allen Hamilton
BAH
$9.38B
-3,388
Closed -$224K
CNMD icon
352
CONMED
CNMD
$1.5B
-50,879
Closed -$4.35M
HFWA icon
353
Heritage Financial
HFWA
$1.21B
-75,406
Closed -$2.23M
HRTG icon
354
Heritage Insurance Holdings
HRTG
$979M
-374,683
Closed -$5.77M
IRBT
355
DELISTED
iRobot
IRBT
-259,739
Closed -$23.8M
LITE icon
356
Lumentum
LITE
$63B
-16,593
Closed -$886K
MC icon
357
Moelis & Co
MC
$4.93B
-104,322
Closed -$3.65M
RVTY icon
358
Revvity
RVTY
$12.9B
-264,604
Closed -$25.5M
SYK icon
359
Stryker
SYK
$133B
-2,535
Closed -$521K
PXD
360
DELISTED
Pioneer Natural Resource Co.
PXD
-101,677
Closed -$15.6M
AGN
361
DELISTED
Allergan plc
AGN
-211,510
Closed -$35.4M
SFLY
362
DELISTED
Shutterfly, Inc.
SFLY
-23,973
Closed -$1.21M

Similar funds

Rothschild & Co Asset Management US's Q3 2019 Portfolio in Review

As of Q3 2019, Rothschild & Co Asset Management US held 362 positions worth $9.24B, down 1.4% from $9.37B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Rothschild & Co Asset Management US's Q3 2019 filing shows 11 new, 110 increased, 214 reduced and 15 closed positions. Its largest new stake was Kimberly-Clark: 314,002 shares worth $44.6M. The largest sale was Pfizer, an estimated $61M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

  • Rothschild & Co Asset Management US's largest Q3 2019 buy was Kimberly-Clark: 314,002 shares worth $44.6M.
  • Rothschild & Co Asset Management US added most to Merit Medical Systems in Q3 2019, an estimated $30M increase.
  • Rothschild & Co Asset Management US's biggest Q3 2019 reduction was Pfizer, cutting an estimated $61M.
  • Rothschild & Co Asset Management US fully exited Essent Group in Q3 2019, selling an estimated $38.1M.
  • Rothschild & Co Asset Management US's ten largest holdings make up 12% of its $9.24B portfolio in Q3 2019.
  • Rothschild & Co Asset Management US opened 11 new positions and closed 15 in Q3 2019.
  • Rothschild & Co Asset Management US's portfolio value fell 1.4% quarter-over-quarter to $9.24B.

Based on Rothschild & Co Asset Management US's 13F filing for Q3 2019, filed 8 Nov 2019.